Research programme: endocrine disorder therapeutics - MBX Biosciences
Alternative Names: Peptide therapeutics - MBX BiosciencesLatest Information Update: 28 Oct 2023
At a glance
- Originator MBX Biosciences
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Endocrine disorders